Kaye, who has held positions at Genzyme and Sarepta Therapeutics — where he led development of the Duchenne muscular ...

Three unrelated children were found to have a de novo deletion in the long non-coding RNA (lncRNA) CHASERR, which is adjacent ...

The 18th Judicial District Attorney's Office announced that James Craig faces two new charges of solicitation to commit ...

This new research sheds light on shared and subtype-specific genetic variations and points to potential targets ...

HT2C functional selectivity and Phase 1 clinical data - NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inc. (NASDAQ: DRUG), a ...

Poster presentations on Phase 2a trial seizure biomarker, preclinical, and Phase 1 clinical dataBOSTON and SAN DIEGO, Nov. 14 ...